NPI registry status
Active
2026 NPPES data Ph.D. Medical Genetics NPI 1285639971 M.D.
Verify on CMS → Mary Paul, M.D.
Ph.D. Medical Genetics in Kalaheo, Hawaii.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 354 in Ph.D. Medical Genetics, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 331 beneficiaries · Ph.D. Medical Genetics avg: 1K
Generic prescribing
89%
generic claims · 11% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
61.1/100
▼ 22 pts below national avg 83.5 · Mid-tier
Industry payments
$24.06
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Mary Paul, M.D. reported a CMS MIPS final score of 61.1/100 - below the 83.5 national average - and filed 3,792 Medicare Part D claims in 2024.
- 61.1/100
- MIPS score · -22 vs avg
- 4K
- Part D claims, 2024
- 89%
- generic prescribing
- $24.06
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mary Paul, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1285639971), first enumerated 06/17/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,792 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 61.1/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$24.06 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1285639971 · Ph.D. Medical Genetics
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-LOW · RX-MID · BOOK-THIN · NEAR-MIPS
- NPI-10 1285639971
- ENUM-LEGACY 2005
- TAX-TRACE 354
- MIPS-LOW 61.1/100
- RX-MID 3,792
- BOOK-THIN 4 in Hawaii
- NEAR-MIPS Khwaja Alim, MD · 2.2
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Khwaja Alim, MD …
Khwaja Alim, MD
58.9 MIPS pts
- Paul · this prov…
Paul · this provider
61.1 MIPS pts
- Gerard Vockley, …
Gerard Vockley, MD, PHD
77.5 MIPS pts
- Floyd Burton, M.…
Floyd Burton, M.D.
79.6 MIPS pts
- Kevin Glinton, M…
Kevin Glinton, M.D.
84.1 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mary Paul, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
61 ≥ 6th percentile 6% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about Mary Paul, M.D.?
Below national averagePrimary specialty
Ph.D. Medical Genetics
Medicare Part D claims
3,792 269% vs specialty avg
MIPS final score
61.1/100 22.4 pts vs avg
Specialty distribution in Hawaii
How Ph.D. Medical Genetics compares to other specialties among Hawaii providers
Medicare quality performance, MIPS
Mary Paul, M.D.'s 2023 MIPS final score plotted against the Ph.D. Medical Genetics national average
- MIPS Final Score
- 61.1/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1285639971 |
|---|---|
| Specialty | Ph.D. Medical Genetics |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/17/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
61.0547
Final Score
Measured-score avg: 83.5
29.1903
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mary Paul, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Samuel Mahelona Memorial Hospital
Koloa, HI
Critical Access Hospitals
CMS CCN: 121306
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mary Paul, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$24
Largest payer
Exact Sciences Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Mary Paul, M.D. - brand share 11.0%
Ph.D. Medical Genetics average
11% brand-name claims vs 89% generic, on 3,792 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,792
Total Claims
$285K
Total Drug Cost
331
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 8,276.3
- Total Day Supply
- 238,784
- Brand vs Generic
- 11% brand / 89% generic
- Brand Drug Cost
- $206K
- Generic Drug Cost
- $78K
- Opioid Claims
- 45 (1.2% rate)
- Antibiotic Claims
- 96
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 0.92
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 22, 65-74: 164, 75-84: 113, 85+: 32
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Mary Paul, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Losartan Potassium
Losartan Potassium
258 claims
- Amlodipine Besylate
Amlodipine Besylate
215 claims
- Atorvastatin Calcium
Atorvastatin Calcium
196 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
184 claims
- Metformin Hcl
Metformin Hcl
175 claims
- Simvastatin
Simvastatin
167 claims
- Losartan-Hydrochlo… 92
Losartan-Hydrochlorothiazide
92 claims
- Allopurinol 86
Allopurinol
86 claims
| Drug | Claims |
|---|---|
| Losartan Potassium | 258 |
| Amlodipine Besylate | 215 |
| Atorvastatin Calcium | 196 |
| Rosuvastatin Calcium | 184 |
| Metformin Hcl | 175 |
| Simvastatin | 167 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 92 |
| Allopurinol | 86 |
| Levothyroxine Sodium | 79 |
| Lisinopril | 78 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ph.D. Medical Genetics Overview
How Mary Paul, M.D. fits within the Ph.D. Medical Genetics landscape nationally.
354
Ph.D. Medical Genetics Providers in US
46
States with Ph.D. Medical Genetics
1,029
Avg Claims per Provider
Mary Paul, M.D.'s 3,792 claims are above the specialty average of 1,029.
Nationwide Ph.D. Medical Genetics peers with similar MIPS or enrollment year
Two federal-record peer sets for Paul, both outside Hawaii so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (61.1 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ph.D. Medical Genetics Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as Paul.
One of 4 Ph.D. Medical Genetics providers enrolled in Hawaii, 3 are shown here.
Compare Ph.D. Medical Genetics nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mary Paul, M.D.'s specialty? ▼
Mary Paul, M.D. specializes in Ph.D. Medical Genetics and practices in Kalaheo, Hawaii. Credentials: M.D..
How much does Mary Paul, M.D. prescribe under Medicare Part D? ▼
In 2024, Mary Paul, M.D. wrote 3,792 Medicare Part D claims totaling $285K in drug costs for 331 beneficiaries.
What is Mary Paul, M.D.'s Medicare quality score? ▼
Mary Paul, M.D. has a CMS MIPS Final Score of 61.1/100 (Quality: 29.2). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mary Paul, M.D. located? ▼
Mary Paul, M.D. is located at 4489 PAPALINA ROAD, Kalaheo, HI, 96741. Phone: (808) 332-8523.
What is Mary Paul, M.D.'s NPI number? ▼
Mary Paul, M.D.'s National Provider Identifier (NPI) is 1285639971, issued on 06/17/2005.
Does Mary Paul, M.D. prescribe more brand-name or generic drugs? ▼
Mary Paul, M.D.'s prescribing is 11% brand-name and 89% generic drugs by claim count, with $206K in brand drug costs.
Does Mary Paul, M.D. prescribe opioids? ▼
Yes, Mary Paul, M.D. had 45 opioid claims in 2024 with an opioid prescribing rate of 1.2%.
How many Ph.D. Medical Genetics providers are there in the US? ▼
There are 354 Ph.D. Medical Genetics providers across 46 states in the US. The average Ph.D. Medical Genetics provider writes 1,029 Medicare Part D claims per year.
What drugs does Mary Paul, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Mary Paul, M.D.'s most frequently prescribed drugs include Losartan Potassium, Amlodipine Besylate, Atorvastatin Calcium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mary Paul, M.D. accept Medicare? ▼
Mary Paul, M.D. appears in CMS Medicare data with 3,792 Part D claims and 331 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mary Paul, M.D.'s credentials? ▼
Mary Paul, M.D.'s NPI is 1285639971 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.